Navigation Links
Cryo-Cell International, Inc. Reports Second Quarter 2008 Results
Date:7/10/2008

vate Ltd. for the license of C'elle technology in India and potentially four neighboring countries further expands the Company's global footprint in Southeast Asia and also reflects growing worldwide interest from both existing Cryo-Cell affiliates and new prospective partners who are keenly eager to introduce C'elle in a broad and diverse range of geographic markets. We anticipate that emerging revenue channels from C'elle technology licenses; processing and storage royalties; and global product distribution may favorably impact the Company's balance sheet over time. At this juncture, we are very pleased with Cryo-Cell's progress and we believe that the Company is well positioned to deliver increased shareholder value in the coming periods."

Based in Oldsmar, Florida, with over 155,000 clients worldwide, Cryo-Cell is one of the largest and most established family cord blood banks. ISO 9001:2000 certified and accredited by the AABB, Cryo-Cell operates in a state-of-the-art Good Manufacturing Practice and Good Tissue Practice (cGMP/cGTP)-compliant facility. Cryo-Cell is a publicly traded company. OTC Bulletin Board Symbol: CCEL. Expectant parents or healthcare professionals may call 1-800-STOR-CELL (1-800-786-7235) or visit http://www.cryo-cell.com. For more information about C'elle visit http://www.celle.com.

Conference Call Details

The company will also host a conference call, to discuss the firm's results and mid-year progress, at 04:30 pm ET. Those wishing to listen to the call can access it toll free in the U.S. at 719-325-4778 and internationally on 877-719-9791 with conference call ID 5857814. Please dial-in at least 10 minutes prior to the start of the call to ensure connection.

The conference call will also be accessible through Cryo-Cell's Web site at http://www
'/>"/>

SOURCE Cryo-Cell International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
2. Cryo-Cell International, Inc. Reports Results for Fiscal 2007
3. Cryo-Cell International, Inc. Reports First Quarter 2008 Results
4. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
5. JPMorgans Principal Investment Management Group to Invest in Chindex International, Inc.
6. Corium International, Inc. Announces Appointment of Phyllis Gardner, M.D. and Daniel G. Welch to Board
7. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
8. Chindex International, Inc. to Present at 2008 UBS Global Healthcare Services Conference
9. Bio-Clean International, Inc. to Present at Bluechip Capital Investment Forum
10. MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer
11. VWR International, LLC Acquires Jencons (Scientific) Ltd, UK
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Francisco, CA (PRWEB) July 24, 2014 ... to be semi-finalists in Livestrong’s Big C Competition. Out ... Health are each headed to the semi-final round. In ... Livestrong’s exclusive three-month accelerator program, complete with mentoring from ... , As part of the angelMD commitment to ...
(Date:7/24/2014)... 2014  Neogen Corporation (Nasdaq: NEOG ) ... potential revenue from new rodenticide research are premature. In ... on July 22, 2014, Neogen,s CEO commented about several ... "It was my intent Tuesday at our ... a new type of rodenticide, but certainly not to ...
(Date:7/24/2014)... 1000 balances – 4 steps – One Recommendation: ... and expertly narrows down the mass of product choices ... terminals. , First, select the working environment, then ... instead) and define the accuracy – it’s really that ... the list to models that fit best with the ...
(Date:7/24/2014)... Draper University, a top program ... announce that for 6 weeks this summer, 39 ... on the Draper University campus in the heart ... focused on entrepreneurship, building real-world skills, and “learning ... its sixth cohort, continues to refresh its curriculum ...
Breaking Biology Technology:3 angelMD Startups Make Livestrong Big C Semi-finals 2Neogen comments on SenesTech 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3
... the United States Patent and Trademark Office might ... Foundation expects the office to review its controversial stem ... for WARF, said the foundation remains confident in the validity ... is likely. , ,"Ninety-five percent of the requests to ...
... high-stakes game of citywide wireless Internet, do deep pockets trump local ... example, the answer might be yes. Earlier this year, Milwaukee was ... in the nation. City officials hoped to have some areas of ... now it looks as though wireless hot spots will have to ...
... Wis. - Wisconsin can create a dynamic, creative ... and shedding its "welfare state" mentality, the leader of ... executives. , ,John Jazwiec, who earlier this year made ... what he acknowledged were radical thoughts before an Economic ...
Cached Biology Technology:WARF expects review of stem cell patents 2WARF expects review of stem cell patents 3Milwaukee runs out of patience with wireless Internet provider 2Milwaukee runs out of patience with wireless Internet provider 3RedPrairie exec calls for 50 percent tax cut 2RedPrairie exec calls for 50 percent tax cut 3RedPrairie exec calls for 50 percent tax cut 4
(Date:7/25/2014)... between autism and disrupted brain development is an ... and is largely unknown. However, thanks to funding ... George Washington University (GW) researcher Anthony-Samuel LaMantia, Ph.D. ... in-depth answers to these key questions in the ... of pharmacology and physiology at the GW School ...
(Date:7/25/2014)... biomedical engineering at the University of Houston, has ... artificial organ development., "Introduction to Tissue Engineering: Applications ... into the field of artificial organ development. Metin ... at UH, served as a series editor on ... other published books on the subject of growing ...
(Date:7/25/2014)... a pleiotropic factor characterized by the existence of ... that confer to the protein deeply different characteristics. ... myelination occurring during development and the different phases ... degeneration, axon regrowth, remyelination and target reinnervation, Researchers ... that the soluble NRG1 upregulation observed in Schwann ...
Breaking Biology News(10 mins):GW researcher receives grant to answer the how and why of autism during development 2University of Houston researcher publishes textbook on tissue engineering 2
... A drug used to treat asthma has been shown ... peptide in the brain that is implicated in the ... University,s School of Medicine. The researchers published their ... an AD Transgenic Mouse Model," in the American ...
... Association for Cancer Research will recognize leaders in the ... in Cancer Research Awards. The 36 recipients will be ... April 2-6. The Minority-Serving Institution Faculty Scholars in ... working at the level of assistant professor or above ...
... virus (HIV), the cause of AIDS, makes use of ... into the host-cell genome, according to a new study ... Cancer Center Arthur G. James Cancer Hospital and ... prevents the virus from completing this critical step in ...
Cached Biology News:Asthma drug could help control or treat Alzheimer's disease 2AACR congratulates recipients of minority-serving institution in cancer research awards 2AACR congratulates recipients of minority-serving institution in cancer research awards 3AACR congratulates recipients of minority-serving institution in cancer research awards 4AACR congratulates recipients of minority-serving institution in cancer research awards 5AACR congratulates recipients of minority-serving institution in cancer research awards 6AACR congratulates recipients of minority-serving institution in cancer research awards 7HIV integration requires use of a host DNA-repair pathway 2